this post was submitted on 26 Dec 2022
1 points (100.0% liked)

Drug Addiction

9 readers
1 users here now

founded 2 years ago
MODERATORS
[email protected]
1
FDA Fast-Tracks Review of Overdose Drug Naloxone for Use Without Prescription (www.wsj.com)
submitted 2 years ago by [email protected] to c/[email protected]
0 comments fedilink hide all child comments
 

Harm Reduction Therapeutics Inc. said its 3 milligram nasal spray naloxone formulation, called Rivive, had three times higher concentration in the blood of 36 participants than naloxone delivered as a shot. The company said Monday that the FDA gave it a target approval date of April 28. The FDA declined to comment.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here